Literature DB >> 5641627

The characterization of soluble amyloid prepared in water.

M Pras, M Schubert, D Zucker-Franklin, A Rimon, E C Franklin.   

Abstract

Amyloid was extracted from the spleen of a patient with primary amyloidosis by homogenizing it at high speed with water after preliminary treatments, first to remove proteins soluble in saline, and then to remove salts. The extracts containing amyloid appeared to be clear at concentrations up to 6 mg/ml of protein. The material gave little sediment on being centrifuged up to 20,000 g for 1 hr, but the protein was sedimented at 100,000 g in 1 hr. The amyloid could be precipitated from the extracts by addition of NaCl to 0.0075 mole/liter or of CaCl(2) to 0.0025 mole/liter. The protein-bound Congo red formed a red precipitate and this property was used to estimate recovery and purity of amyloid during extraction. On electronmicroscopy the isolated amyloid proved to be morphologically pure. It existed either as single filaments measuring 60-80 A in diameter or as large aggregates of these filaments.Freshly isolated amyloid in water sedimented as a single homogeneous peak with an s degrees (20,[unk]) of about 45-50S. On standing, the solution became cloudy and more rapidly sedimenting components appeared. On electrophoresis the material migrated as a homogeneous peak towards the anode. The protein had an amino acid composition different from that of all known serum proteins. It was rich in acidic amino acids and had little cysteine and methionine and no hydroxyproline. The total content of carbohydrate was less than 2%.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5641627      PMCID: PMC297240          DOI: 10.1172/JCI105784

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  [The fine structure of the spleen and liver in experimental amyloidosis].

Authors:  R CAESAR
Journal:  Z Zellforsch Mikrosk Anat       Date:  1960

2.  THE SITE OF FORMATION AND ULTRASTRUCTURE OF AMYLOID.

Authors:  B GUEFT; J J GHIDONI
Journal:  Am J Pathol       Date:  1963-11       Impact factor: 4.307

3.  A study of the fine structure of the amyloid associated with familial Mediterranean fever.

Authors:  A S COHEN; A FRENSDORFF; S LAMPRECHT; E CALKINS
Journal:  Am J Pathol       Date:  1962-11       Impact factor: 4.307

4.  Amyloid. Extraction and preliminary characterization of some proteins.

Authors:  E P BENDITT; D LAGUNOFF; N ERIKSEN; O A ISERI
Journal:  Arch Pathol       Date:  1962-10

5.  Experimental amyloidosis. I. Light and electron microscopic observation of spleen and lymph nodes.

Authors:  W A HEEFNER; G D SORENSON
Journal:  Lab Invest       Date:  1962-08       Impact factor: 5.662

6.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

Authors:  J F WOESSNER
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

7.  Solubility characteristics of isolated amyloid fibrils.

Authors:  D S Newcombe; A S Cohen
Journal:  Biochim Biophys Acta       Date:  1965-07-08

8.  Isolation of highly purified amyloid.

Authors:  Y Ashkenazi; C Hersko; J Gafni; E Sohar; H Heller
Journal:  Isr J Med Sci       Date:  1967 Jul-Aug

9.  A modified procedure for lead staining of thin sections.

Authors:  G MILLONIG
Journal:  J Biophys Biochem Cytol       Date:  1961-12

10.  High-resolution electron microscopic analysis of the amyloid fibril.

Authors:  T Shirahama; A S Cohen
Journal:  J Cell Biol       Date:  1967-06       Impact factor: 10.539

View more
  145 in total

1.  Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure.

Authors:  P Mangione; M Sunde; S Giorgetti; M Stoppini; G Esposito; L Gianelli; L Obici; L Asti; A Andreola; P Viglino; G Merlini; V Bellotti
Journal:  Protein Sci       Date:  2001-01       Impact factor: 6.725

2.  Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy.

Authors:  C Ionescu-Zanetti; R Khurana; J R Gillespie; J S Petrick; L C Trabachino; L J Minert; S A Carter; A L Fink
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Antibody-mediated resolution of light chain-associated amyloid deposits.

Authors:  R Hrncic; J Wall; D A Wolfenbarger; C L Murphy; M Schell; D T Weiss; A Solomon
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 4.  Micropurification techniques in the analysis of amyloid proteins.

Authors:  B Kaplan; S Shtrasburg; M Pras
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

5.  Immunohistological characterisation of amyloid deposits in renal biopsy specimens.

Authors:  R J Fitzmaurice; C Bartley; J McClure; P Ackrill
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

6.  Antibodies to amyloid A protein in rheumatic diseases.

Authors:  C P Maury; A M Teppo
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.

Authors:  P R Hol; A M van Ederen; F W Snel; J P Langeveld; J H Veerkamp; E Gruys
Journal:  Br J Exp Pathol       Date:  1985-06

8.  Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.

Authors:  Masatoshi Omoto; Tadaaki Yokota; Dan Cui; Yoshinobu Hoshii; Hiroo Kawano; Toshikazu Gondo; Tokuhiro Ishihara; Takashi Kanda
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

9.  Nature of amyloid deposits in hypernephroma. Immunocytochemical studies in 2 cases associated with amyloid polyneuropathy.

Authors:  M C Dalakas; S Fujihara; V Askanas; W K Engel; G G Glenner
Journal:  Am J Pathol       Date:  1984-09       Impact factor: 4.307

10.  Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss).

Authors:  F E Dwulet; M D Benson
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.